ArticleClinical case reports2021

Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.

Louisa van den Boom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.